Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Liver Cancer|October 1, 2020
Association between Genetic and Immunological Background of Hepatocellular Carcinoma and Expression of Programmed Cell Death-1Naoshi Nishida, Kazuko Sakai, Masahiro Morita, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 12, 2002
Attenuation of antigen-induced airway hyperresponsiveness in CGRP-deficient miceTomoko Aoki-Nagase, Takahide Nagase, Yoshio Oh-Hashi, et al.
Liver Cancer|December 24, 2021
Higher Enhancement Intrahepatic Nodules on the Hepatobiliary Phase of Gd-EOB-DTPA-Enhanced MRI as a Poor Responsive Marker of Anti-PD-1/PD-L1 Monotherapy for Unresectable Hepatocellular CarcinomaTomoko Aoki, Naoshi Nishida, Kazuomi Ueshima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 10, 2020
Histopathological analysis of autoimmune hepatitis with "acute" presentation: Differentiation from drug-induced liver injuryAkemi Tsutsui, Kenichi Harada, Koichi Tsuneyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 20, 2015
Clinical characteristics and prognosis of non-B non-C hepatocellular carcinoma patients with modest alcohol consumptionYohei Urata, Takahiro Yamasaki, Issei Saeki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 31, 2022
Clinical implication of immune checkpoint inhibitor on the chronic hepatitis B virus infectionSatoru Hagiwara, Naoshi Nishida, Hiroshi Ida, et al.
Liver Cancer|August 20, 2021
Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 AntibodyMasahiro Morita, Naoshi Nishida, Kazuko Sakai, et al.
Cancers|December 11, 2025
No Correlation Between Proteinuria and Renal Function in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: ARISE StudyKazuomi Ueshima, Naoshi Nishida, Satoru Hagiwara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 21, 2022
Progression from early to advanced stage of immune-related cholangitisSatoru Hagiwara, Takeshi Yoshida, Naoshi Nishida, et al.
Liver Cancer|June 19, 2024
Two Distinct Characteristics of Immune Microenvironment in Human Hepatocellular Carcinoma with Wnt/β-Catenin MutationsTomoko Aoki, Naoshi Nishida, Yutaka Kurebayashi, et al.
Pageof 12